
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
As life science companies continue to seek insights from data sources to make drug development more efficient and effective, Parexel International Corporation-global biopharmaceutical services provider-announced the launch of its Connected Journey of data-driven services.
Parexel's Connected Journey consists of over 40 data-driven services, including ForeSite™clinical trial methodology.






